These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 36310656)

  • 1. Pathophysiology of polycystic ovary syndrome revisited: Current understanding and perspectives regarding future research.
    Harada M
    Reprod Med Biol; 2022; 21(1):e12487. PubMed ID: 36310656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles of endoplasmic reticulum stress in the pathophysiology of polycystic ovary syndrome.
    Koike H; Harada M; Kusamoto A; Xu Z; Tanaka T; Sakaguchi N; Kunitomi C; Azhary JMK; Takahashi N; Urata Y; Osuga Y
    Front Endocrinol (Lausanne); 2023; 14():1124405. PubMed ID: 36875481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic dysfunction in polycystic ovary syndrome: Pathogenic role of androgen excess and potential therapeutic strategies.
    Sanchez-Garrido MA; Tena-Sempere M
    Mol Metab; 2020 May; 35():100937. PubMed ID: 32244180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Mechanisms of Laparoscopic Ovarian Drilling and Its Therapeutic Effects in Polycystic Ovary Syndrome.
    Seow KM; Chang YW; Chen KH; Juan CC; Huang CY; Lin LT; Tsui KH; Chen YJ; Lee WL; Wang PH
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33142702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.
    Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
    Endocr Pract; 2015 Nov; 21(11):1291-300. PubMed ID: 26509855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of common risk factors between polycystic ovary syndrome and Alzheimer's disease: a narrative review.
    Sarahian N; Sarvazad H; Sajadi E; Rahnejat N; Eskandari Roozbahani N
    Reprod Health; 2021 Jul; 18(1):156. PubMed ID: 34311759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperandrogenism and Polycystic ovary syndrome: Effects in pregnancy and offspring development.
    Abruzzese GA; Silva AF; Velazquez ME; Ferrer MJ; Motta AB
    WIREs Mech Dis; 2022 Sep; 14(5):e1558. PubMed ID: 35475329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of kisspeptin in androgen-induced hypothalamic endoplasmic reticulum stress and its rescuing effect in PCOS rats.
    Yuan C; Huang WQ; Guo JH; Liu XY; Yang JZ; Chen JJ; Wu Y; Ruan YC; Liu JY; Cui YG; Diao FY; Chan HC
    Biochim Biophys Acta Mol Basis Dis; 2021 Dec; 1867(12):166242. PubMed ID: 34389474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polycystic Ovary Syndrome.
    Azziz R
    Obstet Gynecol; 2018 Aug; 132(2):321-336. PubMed ID: 29995717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The obesogen tributyltin induces features of polycystic ovary syndrome (PCOS): a review.
    Merlo E; Silva IV; Cardoso RC; Graceli JB
    J Toxicol Environ Health B Crit Rev; 2018; 21(3):181-206. PubMed ID: 30015594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA methylation in polycystic ovary syndrome: Emerging evidence and challenges.
    Liu YN; Qin Y; Wu B; Peng H; Li M; Luo H; Liu LL
    Reprod Toxicol; 2022 Aug; 111():11-19. PubMed ID: 35562068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of nutrient supplementation in the management of polycystic ovary syndrome-associated metabolic dysfunctions: A critical review.
    Günalan E; Yaba A; Yılmaz B
    J Turk Ger Gynecol Assoc; 2018 Nov; 19(4):220-232. PubMed ID: 30299265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kisspeptin treatment induces gonadotropic responses and rescues ovulation in a subset of preclinical models and women with polycystic ovary syndrome.
    Romero-Ruiz A; Skorupskaite K; Gaytan F; Torres E; Perdices-Lopez C; Mannaerts BM; Qi S; Leon S; Manfredi-Lozano M; Lopez-Rodriguez C; Avendaño MS; Sanchez-Garrido MA; Vazquez MJ; Pinilla L; van Duin M; Kohout TA; Anderson RA; Tena-Sempere M
    Hum Reprod; 2019 Dec; 34(12):2495-2512. PubMed ID: 31820802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Source and amount of carbohydrate in the diet and inflammation in women with polycystic ovary syndrome.
    Barrea L; Marzullo P; Muscogiuri G; Di Somma C; Scacchi M; Orio F; Aimaretti G; Colao A; Savastano S
    Nutr Res Rev; 2018 Dec; 31(2):291-301. PubMed ID: 30033891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Animal models of polycystic ovary syndrome: A review of hormone-induced rodent models focused on hypothalamus-pituitary-ovary axis and neuropeptides.
    Osuka S; Nakanishi N; Murase T; Nakamura T; Goto M; Iwase A; Kikkawa F
    Reprod Med Biol; 2019 Apr; 18(2):151-160. PubMed ID: 30996678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Animal models of hyperandrogenism and ovarian morphology changes as features of polycystic ovary syndrome: a systematic review.
    Paixão L; Ramos RB; Lavarda A; Morsh DM; Spritzer PM
    Reprod Biol Endocrinol; 2017 Feb; 15(1):12. PubMed ID: 28183310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polycystic ovary syndrome and mitochondrial dysfunction.
    Zhang J; Bao Y; Zhou X; Zheng L
    Reprod Biol Endocrinol; 2019 Aug; 17(1):67. PubMed ID: 31420039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME - PART 2.
    Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
    Endocr Pract; 2015 Dec; 21(12):1415-26. PubMed ID: 26642102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polycystic ovary syndrome and environmental toxins.
    Rutkowska AZ; Diamanti-Kandarakis E
    Fertil Steril; 2016 Sep; 106(4):948-58. PubMed ID: 27559705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial dysfunction: An emerging link in the pathophysiology of polycystic ovary syndrome.
    Shukla P; Mukherjee S
    Mitochondrion; 2020 May; 52():24-39. PubMed ID: 32081727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.